Faster global financial news!
Genscript Biotech's OpenCGT project has reached delivery technology cooperation agreements with multiple companies, with potential total transaction value exceeding 6 billion yuan.
Genscript ProBio's OpenCGT project, launched in 2025, aims to open the capabilities of its AiLNP platform to external companies. Currently, the project has established technical collaborations with companies such as RYZM Genomics, JingTong Life, Grandjoy Holdings Industry Platform, BioThunder AG, and Aicogen Therapeutics, covering fields including cell therapy, gene therapy, fibrosis cell programming, and in vivo immunotherapy, with a potential total transaction value exceeding RMB 6 billion. Among these, BioThunder AG has exercised its option and signed a licensing agreement, and Genscript ProBio has received an exclusive licensing fee of RMB 15 million.
Source：华尔街见闻 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Jetron Therapeutics' MTS-128 drug licensed to Boulevard Bio in the US, has received a $20 million upfront payment, with potential milestone payments up to $1.6 billion.
|
Next: AiTEM, the AI formulation innovation platform developed by AiTEM Therapeutics, has completed its localized deployment at Hengrui Medicine and signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical.
24H Trending
-
1
BlackRock Bitcoin ETF once reached a $100 billion milestone: the fastest ever, current AUM approximately $98.5 billion, annual revenue target $500 million
-
2
Will SOL Coin Collapse? Can Solana Become the Next Ethereum?
-
3
US Treasury Secretary Bessent Reportedly Prepares Measures to Curb Rising Bond Yields
-
4
Thailand's SEC opens consultations on Bitcoin and Ether ETF rules, including foreign custodian standards
-
5
KingData Platform Features and Analysis: One-Stop Blockchain Data Service
-
6
BitDATA Exchange Token BDT: Multi-Entity and Token Analysis, and Scam Alert
-
7
Analysis indicates that Walmart (WMT) saw a 5.1% year-over-year increase in Q2 revenue and a 2.6% rise in U.S. comparable store sales. However, given its P/E ratio of 38x and a dividend yield below 1%, investors are advised to hold off on buying for now.
-
8
Analog Devices (ADI) Q3 Revenue Soared 40% YoY, Net Income Doubled to $1.34 Billion; Q4 Revenue Guidance Implies Another 40% Growth
-
9
BCUG Coin Analysis: The Current State of Blockchain Cuties Universe Governance Token and Market Liquidity
-
10
Mexico Bonds Trade Like Junk After $130 Billion Bailout of Pemex
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
